AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
$564M |
| 2 |
Visa
V
|
$317M |
| 3 |
MSCI
MSCI
|
$297M |
| 4 |
Monster Beverage
MNST
|
$266M |
| 5 |
Dollar General
DG
|
$262M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$480M |
| 2 |
Nike
NKE
|
$442M |
| 3 |
Meta Platforms (Facebook)
META
|
$410M |
| 4 |
Advanced Micro Devices
AMD
|
$310M |
| 5 |
Adobe
ADBE
|
$304M |
Sector Composition
| 1 | Technology | 24.78% |
| 2 | Healthcare | 17.69% |
| 3 | Financials | 13.1% |
| 4 | Consumer Discretionary | 10.63% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
POSH
2801
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $343K | ﹤0.01% |
21,900
+8,800
| +67% | +$138K |
|
2802
Cullinan Oncology
CGEM
$413M
| $342K | ﹤0.01% |
26,700
+2,400
| +10% | +$30.7K |
|
|
AZRE
2803
DELISTED
Azure Power Global Limited
AZRE
| $341K | ﹤0.01% |
61,584
+4,970
| +9% | +$27.5K |
|
|
ICPT
2804
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $340K | ﹤0.01% |
24,370
| – | – |
|
2805
Northrim BanCorp
NRIM
$502M
| $339K | ﹤0.01% |
+8,165
| New | +$339K |
|
2806
Arcturus Therapeutics
ARCT
$485M
| $338K | ﹤0.01% |
22,800
-3,300
| -13% | -$48.9K |
|
2807
Precigen
PGEN
$1.3B
| $338K | ﹤0.01% |
159,500
+25,500
| +19% | +$54K |
|
2808
Merchants Bancorp
MBIN
$1.51B
| $337K | ﹤0.01% |
14,600
+3,000
| +26% | +$69.2K |
|
2809
Protagonist Therapeutics
PTGX
$3.77B
| $337K | ﹤0.01% |
40,000
-6,000
| -13% | -$50.6K |
|
2810
Ecovyst
ECVT
$1.03B
| $336K | ﹤0.01% |
39,800
+13,400
| +51% | +$113K |
|
2811
Phibro Animal Health
PAHC
$1.6B
| $335K | ﹤0.01% |
25,233
-9,962
| -28% | -$132K |
|
2812
American Vanguard Corp
AVD
$159M
| $334K | ﹤0.01% |
17,857
+496
| +3% | +$9.28K |
|
2813
IDEAYA Biosciences
IDYA
$2.38B
| $334K | ﹤0.01% |
22,400
| – | – |
|
2814
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.22B
| $334K | ﹤0.01% |
5,306
+345
| +7% | +$21.7K |
|
2815
MiMedx Group
MDXG
$1.06B
| $333K | ﹤0.01% |
116,200
| – | – |
|
|
CLDT
2816
Chatham Lodging
CLDT
$363M
| $330K | ﹤0.01% |
33,444
-3,500
| -9% | -$34.5K |
|
2817
MacroGenics
MGNX
$126M
| $328K | ﹤0.01% |
94,900
-8,500
| -8% | -$29.4K |
|
|
ALX
2818
Alexander's
ALX
$1.2B
| $327K | ﹤0.01% |
1,563
+202
| +15% | +$42.3K |
|
2819
Boston Omaha
BOC
$425M
| $325K | ﹤0.01% |
14,100
| – | – |
|
|
DSEY
2820
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $324K | ﹤0.01% |
66,600
+36,900
| +124% | +$180K |
|
2821
Texas Community Bancshares
TCBS
$47.9M
| $323K | ﹤0.01% |
+20,828
| New | +$323K |
|
2822
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.6B
| $323K | ﹤0.01% |
+2,266
| New | +$323K |
|
2823
BlackBerry
BB
$2.31B
| $322K | ﹤0.01% |
68,613
+604
| +0.9% | +$2.84K |
|
2824
America's Car Mart
CRMT
$299M
| $322K | ﹤0.01% |
5,273
+2
| +0% | +$122 |
|
2825
OptimizeRx
OPRX
$349M
| $322K | ﹤0.01% |
21,744
+2,105
| +11% | +$31.2K |
|